Related Experiment Video

Updated: Aug 19, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Lipid management in patients with unstable angina pectoris and non-ST-segment elevation acute myocardial infarction

JoAnne M Foody1, Matthew T Roe, Anita Y Chen

  • 1Section of Cardiovascular Medicine, Department of Medicine, Yale School of Medicine, New Haven, Connecticut, USA. joanne.foody@yale.edu

The American Journal of Cardiology
|February 8, 2005
PubMed

Insights

This study examined lipid testing and management in over 40,000 patients hospitalized for unstable angina or non-ST-segment elevation myocardial infarction. It identified key factors influencing lipid testing and management at discharge.

Area of Science:

  • Cardiology
  • Clinical Quality Improvement
  • Health Services Research

Background:

  • Lipid management is crucial for patients with acute coronary syndromes.
  • Adherence to guidelines for lipid testing and management can improve patient outcomes.
  • Quality improvement initiatives aim to enhance guideline implementation.

Purpose of the Study:

  • To characterize current lipid testing and management practices.
  • To identify predictors of lipid testing and management at discharge.
  • To evaluate care patterns within a large quality improvement initiative.

Main Methods:

  • Analysis of data from over 40,000 patients.
  • Inclusion of patients hospitalized with unstable angina or non-ST-segment elevation myocardial infarction.
  • Data collected between March 2000 and March 2003 in US hospitals.

Main Results:

  • Characterization of contemporary lipid testing and management patterns.
  • Identification of significant predictors for lipid testing and management at discharge.
  • Assessment of care delivery within the CRACS initiative.

Conclusions:

  • Understanding current practices is essential for targeted interventions.
  • Identifying predictors can guide strategies to improve lipid management.
  • The findings contribute to optimizing care for acute coronary syndrome patients.

Related Concept Videos

Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...